Skip to content

Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures

Fascia Iliaca Compartment Blocks to Improve Preoperative Pain Control in Elderly Hip Fractures

Status
Withdrawn
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04086914
Enrollment
0
Registered
2019-09-12
Start date
2020-02-01
Completion date
2020-12-01
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures

Brief summary

This study is comparing the use of a peripheral nerve block and standard opioid pain medications in pain control in hip fractures prior to surgery. A peripheral nerve block is a procedure that injects numbing medicine around a nerve to help decrease the pain, motion, and sensation around the painful site temporarily. The purpose of this study is to evaluate if peripheral nerve blocks are more effective for pain control than just standard opioid pain medication while decreasing the amount of side effects from opioid medication.

Interventions

PROCEDURENerve Block

This group will receive a nerve block consisting of 20mL of 5mg/mL ropivicanine and 0.1mL of 10mg'mL dexamethasone.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 50 or older, low energy hip fracture, acute hip fracture

Exclusion criteria

* On anticoagulants, hardware present near injection site, preexisting nerve injury.

Design outcomes

Primary

MeasureTime frameDescription
Mean Baseline Pain score on Visual analogue scale at initial encounter0-60 minutespain is measured 1-10, 1 being the lowest and 10 being the highest
Mean Change from baseline pain score on the visual analogue scale3-8 hours after initial encounterpain is measured 1-10, 1 being the lowest and 10 being the highest

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026